Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report

Bifidobacterium longum (B. longum) ES1 is a probiotic strain capable of modulating microbiome composition, anti-inflammatory activity and intestinal barrier function. We investigated the use of B. Longum ES1 in the treatment of patients with diarrhoea-predominant irritable bowel syndrome (IBS-D). Si...

Descripción completa

Detalles Bibliográficos
Autores principales: Caviglia, Gian Paolo, Tucci, Alessandra, Pellicano, Rinaldo, Fagoonee, Sharmila, Rosso, Chiara, Abate, Maria Lorena, Olivero, Antonella, Armandi, Angelo, Vanni, Ester, Saracco, Giorgio Maria, Bugianesi, Elisabetta, Astegiano, Marco, Ribaldone, Davide Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464152/
https://www.ncbi.nlm.nih.gov/pubmed/32717980
http://dx.doi.org/10.3390/jcm9082353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464152/
https://www.ncbi.nlm.nih.gov/pubmed/32717980
http://dx.doi.org/10.3390/jcm9082353

Ejemplares similares